Prospective Study of FMT for Acute Intestinal GVHD After Allo-HSCT
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Acute intestinal GVHD is the main cause of death after allo-HSCT, and FMT is a new treatment
method for this disease. In this prospective study, the investigators will recruit intestinal
GVHD patients to demonstrate the efficacy and safety of FMT.